Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
qilong tongshen granule
- Development stage
- Unknown
- Lead developer
- Yiling Pharmaceutical
- Administration
- Oral
01
Overview
Qilong Tongshen Granule is a Traditional Chinese Medicine (TCM) developed by Shijiazhuang Yiling Pharmaceutical for the treatment of diabetic kidney disease (DKD). Formulated based on the "collateral disease" (Luo Bing) theory, the preparation contains a combination of herbal ingredients, including Astragalus (Huangqi) and Earthworm (Dilong), designed to tonify Qi, activate blood circulation, and dredge renal collaterals. The drug aims to address the underlying pathology of "Qi deficiency and blood stasis" in diabetic patients. Clinical trials have demonstrated its efficacy in reducing urinary albumin excretion rates and improving renal function in patients with early-to-mid stage diabetic nephropathy. It received marketing approval from China's National Medical Products Administration (NMPA) in January 2024.
- Brand names
- 芪龙通肾颗粒
- Other names
- Qilong Tongshen KeliQilong Tongshen Granules
Beyond the preview
Go deeper on qilong tongshen granule.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on qilong tongshen granule.